NCT05492357

Brief Summary

Procedure: Tooth is extracted, then A-PRF+ is placed inside the socket. After that the ridge dimensions is asses clinically at the baseline) in addition to clinical assessment of the gingival biotype at the baseline. Then patients will be divided into 2 groups: Group 1: 50% of patients will have recurrent Liquid-PRF injections inside the extraction socket every 2 weeks (A-PRF+, followed by recurrent Liquid-PRF) Group 2: 50% of patients without recurrent (just A-PRF+) After 3 months from extraction: both groups will be assessed clinically (gingival biotype) \& (Ridge dimensions) in order to assess the role of recurrent application of Liquid-PRF on these parameters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 1, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 8, 2022

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2022

Completed
Last Updated

November 9, 2022

Status Verified

November 1, 2022

Enrollment Period

2 months

First QC Date

August 1, 2022

Last Update Submit

November 5, 2022

Conditions

Keywords

recurrentLiquid platelet-rich fibrinAdvanced platelet-rich fibrin plusridge preservation

Outcome Measures

Primary Outcomes (2)

  • Ridge dimensions

    assessment of ridge dimensions 3 months after intervention for both groups. At the baseline it was assessed clinically. After 3 months, the flap was released and the ridge width and height were assessed clinically.

    3 months

  • Gingival biotype

    assessment of gingival biotype 3 months after intervention according to gingival thickness (using periodontal probe: if \<1 mm = Thin, while if \>1 =Thick).

    3 months

Study Arms (2)

Advanced platelet-rich fibrin plus + Liquid platelet-rich fibrin

EXPERIMENTAL

A-PRF plus + Liquid-PRF are prepared from the patient's blood.

Other: Liquid platelet-rich fibrinOther: Advanced Platelet-rich fibrin plus

Advanced platelet-rich fibrin plus alone

EXPERIMENTAL

A-PRF+ is prepared from the patient's blood.

Other: Advanced Platelet-rich fibrin plus

Interventions

Liquid platelet-rich fibrin is prepared from the patient's blood and injected into the extraction socket every two weeks (up to 3 months = Just 4 times of application)

Also known as: Liquid-PRF
Advanced platelet-rich fibrin plus + Liquid platelet-rich fibrin

A-PRF+ is placed into the extraction socket immediately after tooth extraction

Advanced platelet-rich fibrin plus + Liquid platelet-rich fibrinAdvanced platelet-rich fibrin plus alone

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women over 18 years of age
  • Indication of a simple extraction (Non-molar tooth)
  • Delivery of signed informed consent
  • Need delayed implant placement in the place of extraction

You may not qualify if:

  • Need for multiple extractions
  • Presence of severe swelling prior to surgery in the extraction area
  • Regular treatment with non-steroidal anti-inflammatory drugs (NSAIDs) or other anti-inflammatory drugs
  • Presence of hematologic disease
  • Previous radiation, chemotherapy, or immunosuppressive treatments
  • Uncontrolled diabetes mellitus, metabolic bone disease, ongoing treatment with bisphosphonates drugs, or pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cezar Lahham

Bethlehem, 00000, Palestinian Territories

Location

Related Publications (1)

  • Lahham C, Ta'a MA, Lahham E, Michael S, Zarif W. The effect of recurrent application of concentrated platelet-rich fibrin inside the extraction socket on the hard and soft tissues. a randomized controlled trial. BMC Oral Health. 2023 Sep 19;23(1):677. doi: 10.1186/s12903-023-03400-5.

MeSH Terms

Conditions

Recurrence

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Human patients: 20 patients who need tooth/ teeth extraction would be selected according to the following criteria: INCLUSION CRITERIA: 1. Men and women over 18 years of age 2. Indication of a simple extraction 3. Delivery of signed informed consent EXCLUSION CRITERIA: 1. Need for multiple extractions 2. Presence of severe swelling prior to surgery in the extraction area 3. Regular treatment with non-steroidal anti-inflammatory drugs (NSAIDs) or other anti-inflammatory drugs 4. Presence of hematologic disease 5. Previous radiation, chemotherapy, or immunosuppressive treatments 6. Uncontrolled diabetes mellitus, metabolic bone disease, ongoing treatment with bisphosphonates drugs, or pregnancy
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 1, 2022

First Posted

August 8, 2022

Study Start

June 15, 2022

Primary Completion

August 15, 2022

Study Completion

October 18, 2022

Last Updated

November 9, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations